BENGALURU / NEW DELHI — Billionaire Deepinder Goyal has begun selling Temple, a temple-attached wearable he says can monitor brain health and ageing by measuring cerebral blood flow outside the lab. Critics and doctors question the device’s medical claims, noting the evidence is preliminary, not peer-reviewed, and its core metric—the Brain Flow index—remains controversial amid concerns over links to longevity or cognitive outcomes. The development, reported on November 10, 2026, has drawn close scrutiny from domain specialists and policy observers examining its wider operational and institutional impact.
Industry executives and digital policy researchers noted that the rapid evolution of enterprise compute infrastructure, artificial intelligence deployment, and cybersecurity compliance standards is reshaping operational priorities across India’s technology corridor.
Regulatory frameworks governing data protection, platform accountability, and sovereign cloud capacity continue to draw sustained engagement from both global technology firms and domestic startups.
